Forbes

Should You Book Profits In Pacific Biosciences of California After A Massive 13x Rally?

Should You Book Profits In Pacific Biosciences of California After A Massive 13x Rally?

After a large 13x rise since the March 23 levels of last year, at the current price of around $36 per share we believe Pacific Biosciences of California stock, a biotechnology company that develops gene sequencing systems, has reached its near-term potential. PACB stock has rallied from $3 to $36…

Source: Forbes – Markets
Date: January 25, 2021, 23:56